<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>8344374</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">33512570</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmc">8344374</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">3599</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.1007/s00345-021-03599-4</article-id></all-ids><extracted-table><table-id>Tab1</table-id><table-label>Table 1</table-label><table-caption>Thirteen regions of interest associated with the bladder-related network</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab1"><label>Table 1</label><caption><p>Thirteen regions of interest associated with the bladder-related network</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">ROI #</th><th align="left">MNI</th><th align="left">Brodmann Area</th><th align="left">Hemisphere</th><th align="left">Area</th></tr></thead><tbody><tr><td align="left">1</td><td char=", ," align="char">52,24,12</td><td align="left">44/45</td><td align="left">Right</td><td align="left">Inferior Frontal Gyrus (IFG)</td></tr><tr><td align="left">2</td><td char=", ," align="char">63,18,18</td><td align="left">44/45</td><td align="left">Right</td><td align="left">Inferior Frontal Gyrus (IFG)</td></tr><tr><td align="left">3</td><td char=", ," align="char">40,35,6</td><td align="left">46</td><td align="left">Right</td><td align="left">Inferior Frontal Gyrus (IFG)</td></tr><tr><td align="left">4</td><td char=", ," align="char">48,4,10</td><td align="left">6</td><td align="left">Right</td><td align="left">Inferior Frontal Gyrus (IFG)</td></tr><tr><td align="left">5</td><td char=", ," align="char">6,-18,57</td><td align="left">6</td><td align="left">Right</td><td align="left">Medial Frontal Gyrus (MFG)</td></tr><tr><td align="left">6</td><td char=", ," align="char">3,-18,57</td><td align="left">6</td><td align="left">Right</td><td align="left">Superior Frontal Gyrus (SFG)</td></tr><tr><td align="left">7</td><td char=", ," align="char">2,2,62</td><td align="left">6</td><td align="left">Right</td><td align="left">Superior Frontal Gyrus (SFG)</td></tr><tr><td align="left">8</td><td char=", ," align="char">-12,-26,66</td><td align="left">4</td><td align="left">Left</td><td align="left">Superomedial M1</td></tr><tr><td align="left">9</td><td char=", ," align="char">12,-24,66</td><td align="left">4</td><td align="left">Right</td><td align="left">Superomedial M1</td></tr><tr><td align="left">10</td><td char=", ," align="char">-2,-16,68</td><td align="left">6</td><td align="left">Left</td><td align="left">Supplementary Motor Area (SMA)</td></tr><tr><td align="left">11</td><td char=", ," align="char">4,-6,64</td><td align="left">6</td><td align="left">Right</td><td align="left">Supplementary Motor Area (SMA)</td></tr><tr><td align="left">12</td><td char=", ," align="char">40,38,38</td><td align="left">9</td><td align="left">Right</td><td align="left">Dorsolateral Prefrontal Cortex (dlPFC)</td></tr><tr><td align="left">13</td><td char=", ," align="char">52,38,12</td><td align="left">46</td><td align="left">Right</td><td align="left">Dorsolateral Prefrontal Cortex (dlPFC)</td></tr></tbody></table></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Thirteen regions of interest associated with the bladder-related network</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="left">ROI #</th><th align="left">MNI</th><th align="left">Brodmann Area</th><th align="left">Hemisphere</th><th align="left">Area</th></tr></thead><tbody><tr><td align="left">1</td><td char=", ," align="char">52,24,12</td><td align="left">44/45</td><td align="left">Right</td><td align="left">Inferior Frontal Gyrus (IFG)</td></tr><tr><td align="left">2</td><td char=", ," align="char">63,18,18</td><td align="left">44/45</td><td align="left">Right</td><td align="left">Inferior Frontal Gyrus (IFG)</td></tr><tr><td align="left">3</td><td char=", ," align="char">40,35,6</td><td align="left">46</td><td align="left">Right</td><td align="left">Inferior Frontal Gyrus (IFG)</td></tr><tr><td align="left">4</td><td char=", ," align="char">48,4,10</td><td align="left">6</td><td align="left">Right</td><td align="left">Inferior Frontal Gyrus (IFG)</td></tr><tr><td align="left">5</td><td char=", ," align="char">6,-18,57</td><td align="left">6</td><td align="left">Right</td><td align="left">Medial Frontal Gyrus (MFG)</td></tr><tr><td align="left">6</td><td char=", ," align="char">3,-18,57</td><td align="left">6</td><td align="left">Right</td><td align="left">Superior Frontal Gyrus (SFG)</td></tr><tr><td align="left">7</td><td char=", ," align="char">2,2,62</td><td align="left">6</td><td align="left">Right</td><td align="left">Superior Frontal Gyrus (SFG)</td></tr><tr><td align="left">8</td><td char=", ," align="char">-12,-26,66</td><td align="left">4</td><td align="left">Left</td><td align="left">Superomedial M1</td></tr><tr><td align="left">9</td><td char=", ," align="char">12,-24,66</td><td align="left">4</td><td align="left">Right</td><td align="left">Superomedial M1</td></tr><tr><td align="left">10</td><td char=", ," align="char">-2,-16,68</td><td align="left">6</td><td align="left">Left</td><td align="left">Supplementary Motor Area (SMA)</td></tr><tr><td align="left">11</td><td char=", ," align="char">4,-6,64</td><td align="left">6</td><td align="left">Right</td><td align="left">Supplementary Motor Area (SMA)</td></tr><tr><td align="left">12</td><td char=", ," align="char">40,38,38</td><td align="left">9</td><td align="left">Right</td><td align="left">Dorsolateral Prefrontal Cortex (dlPFC)</td></tr><tr><td align="left">13</td><td char=", ," align="char">52,38,12</td><td align="left">46</td><td align="left">Right</td><td align="left">Dorsolateral Prefrontal Cortex (dlPFC)</td></tr></tbody></table></div></transformed-table></extracted-table><extracted-table><table-id>Tab2</table-id><table-label>Table 2</table-label><table-caption>Patient demographics and clinical variables</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab2"><label>Table 2</label><caption><p>Patient demographics and clinical variables</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Patient Characteristics (N = 9)</th><th align="left">Mean (range)</th></tr></thead><tbody><tr><td align="left">Age (years)</td><td align="left">54.8 (35–77)</td></tr><tr><td align="left">BMI (kg/m<sup>2</sup>)</td><td align="left">26.9 (19.9–41.8)</td></tr><tr><td align="left">MS duration (years)</td><td align="left">14.7 (1–44)</td></tr><tr><td align="left">%PVR/BC</td><td align="left">45.9 (32.1–81.3)</td></tr><tr><td align="left">Liverpool nomogram percentile</td><td align="left">43.3 (5–96)</td></tr><tr><td align="left">Performing CIC (%)</td><td align="left">1/9 (11.1%)</td></tr><tr><td align="left">DSD (%)</td><td align="left">1/9 (11.1%)</td></tr><tr><td align="left">Voided during fMRI (%)</td><td align="left">3/9 (33.3%)</td></tr><tr><td align="left">NDO during fMRI (%)</td><td align="left">4/9 (44.4%)</td></tr></tbody></table><table-wrap-foot><p>BMI: body mass index; %PVR/BC: % post-void residual/bladder capacity; CIC: clean intermittent catheterization; NDO: neurogenic detrusor overactivity.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Patient demographics and clinical variables</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="left">Patient Characteristics (N = 9)</th><th align="left">Mean (range)</th></tr></thead><tbody><tr><td align="left">Age (years)</td><td align="left">54.8 (35–77)</td></tr><tr><td align="left">BMI (kg/m2)</td><td align="left">26.9 (19.9–41.8)</td></tr><tr><td align="left">MS duration (years)</td><td align="left">14.7 (1–44)</td></tr><tr><td align="left">%PVR/BC</td><td align="left">45.9 (32.1–81.3)</td></tr><tr><td align="left">Liverpool nomogram percentile</td><td align="left">43.3 (5–96)</td></tr><tr><td align="left">Performing CIC (%)</td><td align="left">1/9 (11.1%)</td></tr><tr><td align="left">DSD (%)</td><td align="left">1/9 (11.1%)</td></tr><tr><td align="left">Voided during fMRI (%)</td><td align="left">3/9 (33.3%)</td></tr><tr><td align="left">NDO during fMRI (%)</td><td align="left">4/9 (44.4%)</td></tr></tbody></table></div>BMI: body mass index; %PVR/BC: % post-void residual/bladder capacity; CIC: clean intermittent catheterization; NDO: neurogenic detrusor overactivity.</transformed-table></extracted-table></extracted-tables-set>